Incidence and Predictors of Treatment Failure Among Children Receiving First-Line Antiretroviral Treatment in General Hospitals of Two Zones, Tigray, Ethiopia, 2019

References

• Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS Statistics – 2018 Fact Sheet. UNAIDS; 12 2018.
   Google Scholar
• UNICEF. HIV Epidemiology Among Children and Adolescents: UNICEF; 2017.
   Google Scholar
• UNAIDS. Report on the Global AIDS Epidemic: World Health Organization; 2010.
   Google Scholar
• U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). PEPFAR Strategy for Accelerating HIV/AIDS Epidemic Control (2017-2020). U.S.A; 9 2018.
   Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. WHO; 2016.
   Google Scholar
• Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection: AIDS Info; 2018.
   Google Scholar
• Federal Ministry Of Health. National Guidelines for Comprehensive HIV Prevention, Care, and Treatment. Vol. 5 Addis Ababa, Ethiopia; 2017:256.
   Google Scholar
• World Health Organization. Pocketbook of Hospital Care for Children. 2nded. Geneva, Switzerland; 2013.
   Google Scholar
• World Health Organization. Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach-2010 Revision. WHO; 2010.
   Google Scholar
• WHO. Manual on Pediatrics HIV Care and Treatment for District Hospitals. Geneva, Switzerland; 2011.
   Google Scholar
• Davies M-A, Moultrie H, Eley B, et al. Virologic failure and second-line antiretroviral therapy in children in South Africa-the IeDEA Southern Africa Collaboration. J Acquir Immune Defic Syndr. 2011;56(3):270. doi:10.1097/QAI.0b013e318206061021107266
   PubMed Web of Science ®Google Scholar
• WHO. Paediatric ARV Drug Optimization 2 Meeting Report. Geneva, Switzerland: WHO; 285 2015 12 2014 2.
   Google Scholar
• Barth RE, Tempelman HA, Smelt E, Wensing AM, Hoepelman AI, Geelen SP. Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment. Pediatr Infect Dis J. 2011;30(1):52–56. doi:10.1097/INF.0b013e3181ed2af320631647
   PubMed Web of Science ®Google Scholar
• Germanaud D, Derache A, Traore M, et al. Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali. J Antimicrob Chemother. 2009;65(1):118–124. doi:10.1093/jac/dkp412
   Web of Science ®Google Scholar
• Salou M, Dagnra AY, Butel C, et al. High rates of virological failure and drug resistance in perinatally HIV‐1‐infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo. J Int AIDS Soc. 2016;19(1):20683. doi:10.7448/IAS.19.1.2068327125320
   PubMed Web of Science ®Google Scholar
• Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first-line antiretroviral therapy. BMC Infect Dis. 2012;12(1):197. doi:10.1186/1471-2334-12-19722916836
   PubMed Web of Science ®Google Scholar
• Boender TS, Kityo CM, Boerma RS, et al. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. J Antimicrob Chemother. 2016;71(10):2918–2927. doi:10.1093/jac/dkw21827342546
   PubMed Web of Science ®Google Scholar
• Reepalu A. Antiretroviral Treatment at Ethiopian Health Centers. Lund University; 2017.
   Google Scholar
• Rossouw TM, Nieuwoudt M, Manasa J, et al. HIV drug resistance levels in adults failing first‐line antiretroviral therapy in an urban and a rural setting in South Africa. HIV Med. 2017;18(2):104–114. doi:10.1111/hiv.2017.18.issue-227353262
   PubMed Web of Science ®Google Scholar
• Assefa Y, Gilks CF, Lynen L, et al. Performance of the antiretroviral treatment program in Ethiopia, 2005–2015: strengths and weaknesses toward ending AIDS. Int J Infect Dis. 2017;60:70–76. doi:10.1016/j.ijid.2017.05.01228533167
   PubMed Web of Science ®Google Scholar
• Barth RE, van der Loeff MFS, Schuurman R, Hoepelman AI, Wensing AM. Virological follow-up of adult patients in antiretroviral treatment programs in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2010;10(3):155–166. doi:10.1016/S1473-3099(09)70328-720185094
   PubMed Web of Science ®Google Scholar
• Ciaranello AL, Chang Y, Margulis AV, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review. Clin Infect Dis. 2009;49(12):1915–1927. doi:10.1086/64807919916798
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). 90-90-90. An Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva, Switzerland; 10 2014.
   Google Scholar
• Tigray Regional Health Bureau. Regional Estimates of the Population with the Conversion Factor. Unpublished resources: Tigray Regional Health Bureau; 2018.
   Google Scholar
• Sisay MM, Ayele TA, Gelaw YA, Tsegaye AT, Gelaye KA, Melak MF. Incidence and risk factors of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state, Ethiopia: a retrospective follow-up study. BMJ Open. 2018;8(4):e019181. doi:10.1136/bmjopen-2017-019181
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Shah N, Singh R, Vajpayee M, Kabra SK, Lodha R. Outcome of highly active antiretroviral therapy in HIV-infected Indian children. BMC Infect Dis. 2014;14(1):701. doi:10.1186/s12879-014-0701-225539905
   PubMed Web of Science ®Google Scholar
• Costenaro P, Penazzato M, Lundin R, et al. Predictors of treatment failure in HIV-positive children receiving combination antiretroviral therapy: cohort data from Mozambique and Uganda. J Pediatric Infect Dis Soc. 2014;4(1):39–48. doi:10.1093/jpids/piu03226407356
   PubMed Web of Science ®Google Scholar
• Sebunya R, Musiime V, Kitaka SB, Ndeezi G. Incidence and risk factors for first-line antiretroviral treatment failure among Ugandan children attending an urban HIV clinic. AIDS Res Ther. 2013;10(1):25. doi:10.1186/1742-6405-10-2524215971
   PubMed Web of Science ®Google Scholar
• Yassin S, Gebretekle GB. Magnitude and predictors of antiretroviral treatment failure among HIV‐infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study. Pharmacol Res Perspect. 2017;5(1):e00296. doi:10.1002/prp2.29628596843
   PubMed Web of Science ®Google Scholar
• Mutwa PR, Boer KR, Asiimwe-kateera B, et al. Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study. PLoS One. 2014;9(11):e111948. doi:10.1371/journal.pone.011194825365302
   PubMed Web of Science ®Google Scholar
• Emmett SD, Cunningham CK, Mmbaga BT, et al. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acquir Immune Defic Syndr. 2010;54(4):368. doi:10.1097/QAI.0b013e3181cf488220216225
   PubMed Web of Science ®Google Scholar